Inventor · disambiguated record
Mario Sanches
Also filed as: SANCHES MARIO
17 granted patents·5 pending applications·105 citations·filing 2013–2025
93Inventor score
Top patents by PatentIndex Score
22 records- 0196US10000576B1Bispecific antigen-binding constructs targeting HER2ZYMEWORKS INC·Filed 2018·Granted Jun 19, 2018·23 cites·30 claims
- 0292US9914785B2Engineered immunoglobulin heavy chain-light chain pairs and uses thereofZYMEWORKS INC·Filed 2013·Granted Mar 13, 2018·17 cites·15 claims
- 0391US11286293B2Engineered immunoglobulin heavy chain-light chain pairs and uses thereofZYMEWORKS INC·Filed 2018·Granted Mar 29, 2022·6 cites·25 claims
- 0491US11161915B2Antigen-binding polypeptide constructs comprising kappa and lambda light chains and uses thereofZYMEWORKS INC·Filed 2016·Granted Nov 2, 2021·7 cites·26 claims
- 0591US9388231B2Multivalent heteromultimer scaffold design and constructsZYMEWORKS INC·Filed 2013·Granted Jul 12, 2016·16 cites·38 claims
- 0690US11306156B2Modified antigen binding polypeptide constructs and uses thereofZYMEWORKS INC·Filed 2015·Granted Apr 19, 2022·7 cites·37 claims
- 0790US11078296B2Engineered immunoglobulin heavy chain-light chain pairs and uses thereofZYMEWORKS INC·Filed 2018·Granted Aug 3, 2021·5 cites·12 claims
- 0890US10077298B2Engineered immunoglobulin heavy chain-light chain pairs and uses thereofZYMEWORKS INC·Filed 2013·Granted Sep 18, 2018·15 cites·22 claims
- 0990US2025122305A1Bispecific antigen binding constructs targeting her2ZYMEWORKS BC INC·Filed 2024·Application pending·0 cites
- 1089US11325981B2Bispecific antigen-binding constructs targeting Her2ZYMEWORKS INC·Filed 2018·Granted May 10, 2022·2 cites·19 claims
- 1189US10947319B2Bispecific antigen-binding constructs targeting HER2ZYMEWORKS INC·Filed 2014·Granted Mar 16, 2021·5 cites·18 claims
- 1281US12215166B2Bispecific antigen binding constructs targeting HER2ZYMEWORKS BC INC·Filed 2022·Granted Feb 4, 2025·0 cites·23 claims
- 1378US10358479B2Multivalent heteromultimer scaffold design and constructsZYMEWORKS INC·Filed 2016·Granted Jul 23, 2019·2 cites·24 claims
- 1476US11965036B2Bispecific antigen-binding constructs targeting HER2ZYMEWORKS BC INC·Filed 2021·Granted Apr 23, 2024·0 cites·19 claims
- 1572US12304945B2Engineered immunoglobulin heavy chain-light chain pairs and uses thereofZYMEWORKS BC INC·Filed 2022·Granted May 20, 2025·0 cites·20 claims
- 1671US12286489B2Modified antigen binding polypeptide constructs and uses thereofZYMEWORKS BC INC·Filed 2022·Granted Apr 29, 2025·0 cites·40 claims
- 1769US12060436B2Engineered immunoglobulin heavy chain-light chain pairs and uses thereofZYMEWORKS BC INC·Filed 2021·Granted Aug 13, 2024·0 cites·14 claims
- 1868US11248037B2Multivalent heteromultimer scaffold design and constructsZYMEWORKS INC·Filed 2019·Granted Feb 15, 2022·0 cites·36 claims
- 1967US2025215115A1Modified antigen bindingpolypeptide constructs and uses thereofZYMEWORKS BC INC·Filed 2025·Application pending·0 cites
- 2051US2024115603A1Modified Extracellular Domain of Granulocyte Colony-Stimulating Factor Receptor (G-CSFG) and Cytokines Binding SameZYMEWORKS INC·Filed 2020·Application pending·0 cites
- 2149US2025222128A1Antibody drug-conjugates targeting c-met and methods of use thereofZYMEWORKS BC INC·Filed 2025·Application pending·0 cites
- 2239US2019367612A1Anti-gprc5d antibody and molecule containing sameDAIICHI SANKYO CO LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mario Sanches files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →